[(18)F]FMISO PET/CT as a preoperative prognostic factor in patients with pancreatic cancer

BACKGROUND: While [(18)F]fluoromisonidazole (FMISO), a representative PET tracer to detect hypoxia, is reported to be able to prospect the prognosis after treatment for various types of cancers, the relation is unclear for pancreatic cancer. The aim of this study is to assess the feasibility of [(18...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamane, Tomohiko, Aikawa, Masayasu, Yasuda, Masanori, Fukushima, Kenji, Seto, Akira, Okamoto, Koujun, Koyama, Isamu, Kuji, Ichiei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509312/
https://www.ncbi.nlm.nih.gov/pubmed/31073705
http://dx.doi.org/10.1186/s13550-019-0507-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509312/
https://www.ncbi.nlm.nih.gov/pubmed/31073705
http://dx.doi.org/10.1186/s13550-019-0507-8

Ejemplares similares